Foghorn Therapeutics Inc. - Common Stock financial statements
Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.
Filed statements
| USD; millions except EPS | Jun 2026Filed 06/08/2026 | Mar 2026Filed 06/08/2026 | Sep 2025Filed 05/11/2025 | Jun 2025Filed 06/08/2026 | Mar 2025Filed 06/08/2026 | Sep 2024Filed 05/11/2025 | Jun 2024Filed 05/11/2025 | Mar 2024Filed 05/11/2025 |
|---|---|---|---|---|---|---|---|---|
| $16 | $3.3 | $8.2 | $7.6 | $6 | $7.8 | $6.9 | $5.1 | |
| −$7.2 | −$20 | −$16 | −$18 | −$19 | −$19 | −$23 | −$25 | |
| −$0.10 | −$0.29 | −$0.25 | −$0.28 | −$0.30 | −$0.31 | −$0.45 | −$0.59 | |
| 71 | 70 | 63 | 63 | 63 | 63 | 52 | 42 |
Trend